Bioseet is a digital partnering tool to initiate innovative medicines, biosimilars and generics deals. On the bioseet platform customers can 1. Search for available innovative medicines, biosimilar and generics assets - asset information includes key asset data, the actual project development status and the aspired playing field, i.e. deal structure and partner capabilities 2. Evaluate asset opportunities within teams via asset related votings, recommendations and team-chat-rooms 3. Exchange information with asset vendor via anonymous chat-room and option to mutually disclose identity and contact information. Bioseet was founded 2019 by Olaf Ucksche.
